Showing 1 - 10 of 27
its current drug reimbursement process because of budgetary constraints. One method of achieving this is to implement a … importance in the decision making around drug reimbursement. Second, a set of priority treatments to be assessed was determined …. Once the treatments eligible for reimbursement were determined, scores were assigned to these treatments according to their …
Persistent link: https://www.econbiz.de/10011005062
the value and subsequent reimbursement of new and existing drugs, as well as reforms to obtain low prices for generic …
Persistent link: https://www.econbiz.de/10005243086
Background:Background: The Common Drug Review (CDR) was created to provide a single process to review the comparative clinical efficacy and cost effectiveness of new drugs, and then to make formulary listing recommendations to Canadian publicly funded drug benefit plans. Abstract:...
Persistent link: https://www.econbiz.de/10009493382
Background: Consideration of public preferences is desirable when making decisions on the subsidy of pharmaceuticals. Little is known about the preferences of the public for pharmaceutical funding decisions, and no study has directly compared the preferences of members of a pharmaceutical...
Persistent link: https://www.econbiz.de/10010614261
Reimbursement Committee (DRC) evaluates reimbursement requests for orphan drugs based on multiple criteria: the therapeutic value …, price and proposed reimbursement tariff; the importance of the drug in clinical practice; and the budget impact of the drug …. Objectives: This study aimed to assess reimbursement dossiers of orphan drugs in Belgium and to compare them with the clinical …
Persistent link: https://www.econbiz.de/10010614358
Background: Attempts to improve the acceptability of resource allocation decisions around new health technologies have spanned many years, fields and disciplines. Various theories of decision making have been tested and methods piloted, but, despite their availability, evidence of sustained...
Persistent link: https://www.econbiz.de/10010614366
Persistent link: https://www.econbiz.de/10010614367
costly orphan drugs because access depends primarily on co-payments, reimbursement policies and prices. The objective of this …
Persistent link: https://www.econbiz.de/10010614375
This work aims to provide a systematic and updated survey of original scientific studies on the effect of the introduction of reference pricing (RP) policies in Organisation for Economic Co-operation and Development (OECD) countries. We searched PubMed, EconLit and Web of Knowledge for articles...
Persistent link: https://www.econbiz.de/10010614402
Asian healthcare systems are very diverse, representing cultures, political systems and economies from more than 30 countries with varying histories. Despite the diversity in the region, there has been enormous growth in health economics and outcomes research since the beginning of the 21st...
Persistent link: https://www.econbiz.de/10008519880